Status:
COMPLETED
A Small Clinical Study: Photodynamic Therapy to Treat Hidradenitis Suppurativa
Lead Sponsor:
University of Kansas
Collaborating Sponsors:
DUSA Pharmaceuticals, Inc.
Conditions:
Hidradenitis Suppurativa
Eligibility:
All Genders
18-55 years
Phase:
NA
Brief Summary
This study will investigate the efficacy of Photodynamic Therapy (PDT), which is the therapeutic use of photochemical reactions, in treating hidradenitis suppurativa (HS), a chronic inflammatory condi...
Detailed Description
This study will investigate the efficacy of PDT using aminolevulinic acid (ALA) and either blue light or intense pulsed light on active lesions of HS. We will attempt to validate the success noted in ...
Eligibility Criteria
Inclusion
- multiple lesions consistent with HS in axillae/groin
- history of no or poor response to at least one treatment modality
- no active treatment in the 2 weeks prior to study initiation
Exclusion
- Pregnancy/lactation
- photosensitizing drug use within 30 days of start of study
- active infection needing antibiotics
- history of porphyria or photosensitivity
Key Trial Info
Start Date :
October 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2007
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT00395187
Start Date
October 1 2006
End Date
September 1 2007
Last Update
October 10 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Kansas Medical Center
Kansas City, Kansas, United States, 66160